首页> 美国卫生研究院文献>Clinical Microbiology Reviews >Measles control in the United States: problems of the past and challenges for the future.
【2h】

Measles control in the United States: problems of the past and challenges for the future.

机译:美国的麻疹控制:过去的问题和未来的挑战。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Elimination of indigenous measles from the United States has been a public priority since 1978. To assess the progress made toward this goal, we review the epidemiology of measles from 1963 to the present. From the 1970s through early into the recent measles epidemic, the majority of measles cases were in highly vaccinated, school-age children. This was due primarily to a 1 to 5% primary measles-mumps-rubella vaccine failure rate and nonrandom mixing patterns among school-age populations. To eliminate susceptible individuals in the school-age populations, a second dose of measles vaccine is now recommended between 5 and 6 years or 11 and 12 years by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Later in the epidemic, measles cases surged among unimmunized preschool children, especially among the poor in inner-city areas. Immunization rates have been documented to be low among preschool populations because of missed opportunities to administer vaccines at all health visits and barriers to access to immunizations. To raise immunization rates, the age for the first measles-mumps-rubella immunization was lowered to 12 to 15 months of age, federal immunization funding has increased, and new standards for immunization delivery have been developed and promulgated.
机译:自1978年以来,从美国消除麻疹一直是公共优先事项。为了评估在实现这一目标方面取得的进展,我们回顾了1963年至今的麻疹流行病学。从1970年代到最近的麻疹流行早期,大多数麻疹病例是在高度接种疫苗的学龄儿童中发生的。这主要是由于1至5%的初次麻疹-腮腺炎-风疹疫苗接种失败率和学龄人口之间的非随机混合方式所致。为了消除学龄人群中的易感人群,免疫实践咨询委员会和美国儿科学会现在建议在5至6岁或11至12岁之间接种第二剂麻疹疫苗。在流行病后期,未免疫的学龄前儿童,特别是内城区贫困人口中的麻疹病例激增。据记录,学龄前人群的免疫率很低,因为在所有健康访问中都错过了接种疫苗的机会,而且获得免疫的障碍也很多。为了提高免疫率,第一次麻疹-腮腺炎-风疹免疫的年龄降低到12至15个月大,联邦免疫资金增加,并且制定了新的免疫标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号